Quick Answer
LakeShore Biopharma Co., Ltd. reported Stockholders Equity of $69.62 million for the year ending 2025.
- LakeShore Biopharma Co., Ltd. showed a decrease of -88.1% in Stockholders Equity from 2024 to 2025.
- This data is from LakeShore Biopharma Co., Ltd.'s annual report (Form 10-K), filed with the SEC on July 31, 2025.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), LakeShore Biopharma Co., Ltd.'s Stockholders Equity has grown by 108.2%.
- Historical annual values: Fiscal year 2025: $69.62 million | Fiscal year 2024: $585.21 million | Fiscal year 2023: $728.45 million | Fiscal year 2022: -$698.97 million | Fiscal year 2021: -$508.86 million | Fiscal year 2020: -$847.32 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: